[Myocardial ischaemia detection in women].
Screening of myocardial ischemia refers to the use of one or more diagnostic tests for coronary heart disease with a dual objective of appropriateness and promptness. In women, as compared to men, the accuracy of the different tests is worse. Thus, to overcome this sex-related penalty, we must define a diagnosis strategy based on risk stratification, enabling the identification of patients requiring invasive investigations. This review discusses various non-invasive diagnostic tests focusing on a female-specific approach and defines the use of numerous diagnostic tests with respect to both risk stratification and symptoms.
Unité de cardiologie interventionnelle, polyclinique de Courlancy, 38, rue de Courlancy, 51100 Reims, France.
S
S
Duval
Unité de cardiologie interventionnelle, polyclinique de Courlancy, 38, rue de Courlancy, 51100 Reims, France.
M
M
Leroux
Unité de cardiologie interventionnelle, polyclinique de Courlancy, 38, rue de Courlancy, 51100 Reims, France.
Y
Y
Davienne
Unité de cardiologie interventionnelle, polyclinique de Courlancy, 38, rue de Courlancy, 51100 Reims, France. Electronic address: camille.brasselet@orange.fr.
C
C
Brasselet
D003327:Coronary Disease / Q000175:diagnosis* / Q000453:epidemiology; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008403:Mass Screening; D017202:Myocardial Ischemia / Q000175:diagnosis* / Q000453:epidemiology; D011237:Predictive Value of Tests; D012737:Sex Factors
Coronaropathie; Coronary artery disease; Diagnosis; Femmes; Ischémie myocardique; Myocardial ischemia; Test diagnostique; Women